Literature DB >> 15842361

Provisional criteria for the diagnosis of VWD type 1.

J E Sadler1, F Rodeghiero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15842361     DOI： 10.1111/j.1538-7836.2005.01245.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  17 in total

Review 1.  Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency.

Authors:  P James; O Salomon; D Mikovic; F Peyvandi
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

2.  A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.

Authors:  Flora Peyvandi; Giancarlo Castaman; Paolo Gresele; Raimondo De Cristofaro; Piercarla Schinco; Antonella Bertomoro; Massino Morfini; Gabriella Gamba; Giovanni Barillari; Víctor Jiménez-Yuste; Cristoph Königs; Alfonso Iorio; Augusto B Federici
Journal:  Blood Transfus       Date:  2019-02-04       Impact factor: 3.443

Review 3.  Diagnostic approach to von Willebrand disease.

Authors:  Christopher Ng; David G Motto; Jorge Di Paola
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

Review 4.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 5.  Making a diagnosis of VWD.

Authors:  Brian R Branchford; Jorge Di Paola
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 6.  Phenotyping bleeding.

Authors:  Paula James; Barry S Coller
Journal:  Curr Opin Hematol       Date:  2012-09       Impact factor: 3.284

7.  Utility of International Society on Thrombosis and Hemostasis Bleeding Assessment Tool (ISTH-BAT) in Patients with Inherited Bleeding Disorders: A Cross-Sectional Study from Southern India.

Authors:  Pagadalu Lokababu Ambika; Debdatta Basu; Sukesh Chandran Nair; Rakhee Kar
Journal:  Indian J Hematol Blood Transfus       Date:  2021-04-15       Impact factor: 0.900

8.  Optimization of the automated, CS-2000i™ method for measuring low levels of von Willebrand factor ristocetin cofactor activity (VWF:RCo).

Authors:  Tomoko Matsumoto; Keiji Nogami; Masahiro Okuda; Midori Shima
Journal:  Int J Hematol       Date:  2014-12-06       Impact factor: 2.490

Review 9.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

Review 10.  Current controversies in the diagnosis and management of von Willebrand disease.

Authors:  Anne T Neff
Journal:  Ther Adv Hematol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.